Tag: biotech penny stocks

4 Top Biotech Stocks To Be Purchased On The Cheap

4 Top Biotech Stocks To Be Purchased On The Cheap

| October 18, 2016 | 1 Comment

Biotech stocks took a tumble last week, but for the long-term investor these valuations are a gift. Snap up shares of these four promising stocks for a discount today and take advantage of these too-low prices. Last week was brutal for biotech investors. The main indices dropped more than six percent just in Tuesday’s and […]

Continue Reading

4 Takeover Targets In The Market’s Hottest Sector

4 Takeover Targets In The Market’s Hottest Sector

| October 11, 2016 | 0 Comments

There has been a fast and furious resurgence in M&A in this sector with tens of billions of dollars of deals going down in just the last couple of months. With expectations that dealmaking will continue to increase, consider these four stocks as solid investments with the chance for huge returns if they are purchased […]

Continue Reading

4 Must-Own Biotech Stocks As The Sector Comes Charging Back

4 Must-Own Biotech Stocks As The Sector Comes Charging Back

| September 29, 2016 | 0 Comments

Up 20% over the last three months, the biotech sector has come roaring back with a vengeance. Given the positive outlook for this sector, Bret Jensen shares his four “must-own” picks through year-end. After three quarters of significantly underperforming the overall market, the biotech sector has roared back in a big way so far in […]

Continue Reading

Buy These 3 Stocks Insiders Love

Buy These 3 Stocks Insiders Love

| September 27, 2016 | 0 Comments

When insiders step up and put millions of their own dollars on the line to purchase company stock, investors should take notice. Don’t wait to only then see these stocks on CNBC rocketing up double-digits, buy shares today. After over two decades of successfully investing in the volatile and lucrative small biotech space, I have […]

Continue Reading

The Next 3 Major Biotech Takeover Targets

The Next 3 Major Biotech Takeover Targets

| September 22, 2016 | 0 Comments

After record years for deal volume in both 2014 and 2015 in the biotech and pharma industries, M&A transactions have posted a significant decline in the volume of deals so far in 2016 across these industries. As of late August, transactions based on dollar volume were down almost 65% from the same period in 2015. […]

Continue Reading

3 Biotech Stocks That Can Double Before The End Of 2016

3 Biotech Stocks That Can Double Before The End Of 2016

| September 8, 2016 | 0 Comments

And, that is no exaggeration, these three biotech stocks all have near-term catalysts right around the corner that will send their currently undervalued share prices soaring when positive. Grab shares today because the catalysts we’re targeting for growth start happening in September. One of the keys to investing in the small cap portion of the […]

Continue Reading

4 Undervalued Growth Stocks Deserving Your Interest

4 Undervalued Growth Stocks Deserving Your Interest

| August 23, 2016 | 0 Comments

Pick up your pen and paper and write down the names of these four stocks that right now trade for valuations too low for their potential growth. With most stocks tading for premiums right now, finding four growth stocks with attractive valuations to add to your portfolio is worth your attention. I have followed and […]

Continue Reading

4 Stocks To Buy With The Spread Of Zika

4 Stocks To Buy With The Spread Of Zika

| August 16, 2016 | 0 Comments

The Zika virus has been all over the news recently. It obviously is a backdrop for the Summer Olympics given the host country Brazil is the epicenter for this recent outbreak. The President and Congress continue to duel it out on assigning funding to tackle the virus from spreading further than it already has in […]

Continue Reading

4 Likely Biotech Takeover Targets To Buy

4 Likely Biotech Takeover Targets To Buy

| July 26, 2016 | 0 Comments

After biotech stock Relypsa was bought out last week for a 60% premium, the odds of M&A heating up in this sector increased dramatically. Bret Jensen shares four more likely takeover targets that should be on your watchlist. It was a good week for the Biotech Gems portfolio. Progenics Pharmaceuticals (NASDAQ: PGNX) leapt 25% in […]

Continue Reading

Buy These 5 Undervalued Biotech Stocks On Sale Today

Buy These 5 Undervalued Biotech Stocks On Sale Today

| May 19, 2016 | 0 Comments

One, two, or three years out, investors will probably look back on the entry points in these five stocks and wonder why they did not allocate more funds to them. With growing earnings and revenues and M&A heating up, these five stocks are screaming buys right now. I was out at the Money Show in […]

Continue Reading

The One Hit Wonder

The One Hit Wonder

| May 17, 2016 | 0 Comments

How connected are you?  If you take away Facebook friends and second & third degree Twitter connections, how many influential people do you know?  I have met a couple of famous athletes and entertainers.  I have even had meetings with mutual fund managers (the dullest people on earth).  I know a few movers and shakers […]

Continue Reading